• Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.

    Children's HealthGene SequencingInnovationNeurodegenerative DiseaseRare Diseases
  • Read how nature's medicine chest empowers our drug discovery chemists to advance biomedical research

    Drug DiscoveryGene SequencingNovartis Institutes for BioMedical ResearchClinical ResearchBiomedical JobsDrug Design
  • A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.

    Gene SequencingNext Generation ScientistNovartis Institutes for BioMedical ResearchNext Generation SequencingScientific Discoveries
  • Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.

    Biomedical ResearchGene SequencingNovartis Institutes for BioMedical ResearchReimagine MedicineNext Generation SequencingGenetic Disease
  • Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.

    Gene SequencingInnovationNovartis Institutes for BioMedical ResearchGene Testing
  • Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.

    Biomedical ResearchGene SequencingNovartis Institutes for BioMedical ResearchNext Generation SequencingScientific DiscoveriesCancer Research Institute